T1	Participants 35 60	malaria chemoprophylaxis:
T2	Participants 161 333	users of malaria chemoprophylaxis regimens (atovaquone-proguanil, chloroquine-proguanil, doxycycline, or mefloquine) in a group of nonimmune tourists to sub-Saharan Africa.
T3	Participants 427 477	travel clinics in Switzerland, Germany, and Israel
T4	Participants 536 544	(n= 547)
T5	Participants 1444 1501	age group (below median age 34 y vs median age and above)
T6	Participants 1633 1656	aged 34 years and older
T7	Participants 1658 1694	Younger participants, aged <34 years
T8	Participants 1845 1887	standard malaria chemoprophylaxis regimens
T9	Participants 1978 2017	younger persons aged less than 34 years
T10	Participants 2101 2120	older counterparts.
